 |
 |
PDF
Phase II trial of single-agent oral vinorelbine in elderly ( 70 years) patients with...
Camerini et al. Ann Oncol.2009;
0:
mdp525v1-mdp525
|
|
 |
 |
 |
| To view this item, select one of the options below: |
 |
 |
 |
 |
Sign In |
 |
|
 |
 |
 |
 |
Purchase Short-Term Access |
 |
 |
Pay per View - If you would like to purchase short-term access you must have a personal account. Please sign in with your personal user name and password or register to obtain a user name and password for free. You may access this article for 1 day for US$32.00. |
 |
 |
 |
 |
Login via Athens or your institution |
 |
 |
 |
 |
Register or Subscribe |
 |
 |
Subscribe to the Journal - Subscribe to the print and/or online journal. |
 |
 |
 |
Register - Register online for access to selected content and to use Pay per View. Registration is free. |
 |
 |
 |
 |